NCT06497816 Health Literacy, Physical and Cognitive Function, Health-related Behaviors, and Quality of Life in COPD
| NCT ID | NCT06497816 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | COPD |
| Study Type | OBSERVATIONAL |
| Enrollment | 144 participants |
| Start Date | 2024-06-15 |
| Primary Completion | 2027-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 144 participants in total. It began in 2024-06-15 with a primary completion date of 2027-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Health literacy is important for controlling disease progression and living a healthy life with illness. High health literacy is associated with higher cognitive performance and lower health-related quality of life. Physical, psychological, and social impairments are seen in chronic obstructive pulmonary disease (COPD). Studies investigating the relationship between health literacy and functional capacity, quality of life, physical activity, cognitive function, health-related behavior, and activities of daily living in individuals with COPD are limited. Therefore, the aim of this study was to compare individuals with COPD with healthy individuals in terms of health literacy, functional capacity, quality of life, physical activity, cognitive function, health-related behavior, and activities of daily living and to investigate the relationship between health literacy and functional capacity, quality of life, physical activity, cognitive function, health-related behavior, and activities of daily living in individuals with COPD.
Eligibility Criteria
Inclusion criteria for the COPD group: * Being over 40 years old, * Diagnosed with COPD and being clinically stable, * Being able to cooperate with the tests to be performed, * Not having any cardiovascular disease, orthopedic or neurological problems that may affect the tests, * Being willing to participate in the study. Exclusion criteria for the COPD group: * Being in an acute exacerbation period, * Having any cardiovascular disease, orthopedic or neurological problems that may affect the tests, * Not being willing to participate in the study. Inclusion criteria for the control group: * Being willing to participate in the study and being over 40 years old * Not having any known disease Exclusion criteria for the control group: * Not being able to cooperate with the tests to be performed * Not being willing to participate in the study
Contact & Investigator
Aslihan Cakmak-Onal, PhD, PT
PRINCIPAL INVESTIGATOR
Hacettepe University
Frequently Asked Questions
Who can join the NCT06497816 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06497816 currently recruiting?
Yes, NCT06497816 is actively recruiting participants. Contact the research team at aslihancakmak90@gmail.com for enrollment information.
Where is the NCT06497816 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06497816 clinical trial?
NCT06497816 is sponsored by Hacettepe University. The principal investigator is Aslihan Cakmak-Onal, PhD, PT at Hacettepe University. The trial plans to enroll 144 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.